1 

TCE EXPERTS BIOSKETCHES 

Dr. Raymond Bruce Runyan is Professor of Cellular and Molecular Medicine at the University 

of Arizona. He earned his B.A. degree from Macalester College, St. Paul, Minnesota (Biology); 

his M.S. degree from Florida State University, Tallahassee, Florida (Biology /Genetics); and his 

Ph.D. degree from Texas Tech University Health Sciences Center, Lubbock, Texas (Cell Biology 

and Biochemistry). Dr. Runyan served as an assistant professor at the University of Iowa’s 

Department of Anatomy from 1986 to 1992, when he was appointed to the department as 

associate professor with tenure. In 1992, he served on the University of Arizona’s Department of 

Anatomy as associate professor, until he was appointed associate professor with tenure in 1994 

in the University of Arizona’s Department of Cell Biology and Anatomy and professor of 

Cellular and Molecular Medicine in 2000 (the department changed its name in 2011). His 

research interests include the effects of TCE exposure on valve-forming endothelial cells and on 

contraction in heart muscle cells. Since 1992, Dr. Runyan also has served as a scientist for the 

University of Arizona’s Saver Heart Center, and since 1993 as member of the university’s 

Physiological Sciences Graduate Program. In addition, since 2000 he has been a member of the 

Steele Memorial Children’s Center and Arizona Cancer Center. He has served as an ad hoc

reviewer for the National Science Foundation, National Institutes of Health (NIH), National 

Cancer Institute, and National Heart, Lung, and Blood Institute, as well as serving on the 

American Heart Association’s Brain, Lung, and Development Research Study Committee (1989-

1992) and Great Plains Review Committee (1999). He was a member of the Human Embryology 

and Development 2 (1994-1997) and Cardiac Differentiation and Development (2006-2010) 

study sections for NIH. Dr. Runyan has served on numerous national, university, collegiate and 

departmental committees, including The Epithelial-Mesenchymal Transition International 

Association (TEMTIA), where he was director and secretary (2006-2007), vice president (2007-

2008), and president (2008-2009) and has served on the Executive Board since 2010. He has 

served on four journal editorial boards and been a reviewer for 31 journals. He has published 57 

refereed publications, authored 17 books or chapters of books, and made dozens of invited 

speeches and presentations at national and international conferences. 

Dr. Deborah Keil is Associate Professor with the Department of Microbiology, Medical 

Laboratory Sciences, at Montana State University in Bozeman. She received her B.S. degree in 

Clinical Laboratory Science from Western Carolina University, North Carolina, and her Ph.D. 

degree in Biology (Immunotoxicology) from Mississippi State University. Dr. Keil served as 

assistant professor in the Medical University of South Carolina (MUSC) Department of Medical 

Laboratory Sciences (1999-2002) before being promoted to associate professor (2000-2002). 

After a position as a research toxicologist in the Agriculture and Immunotoxicology Group, 

Office of the Director, and Analytical Science Branch, Health Effects Laboratory Division at the 

National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and 

Prevention (2002-2004), Dr. Keil held an appointment as associate professor, Clinical 

Laboratory Science Program, School of Allied Health, University of Nevada, Las Vegas (2005-

2010), and was professor (lecturer track) at the University of Utah, School of Medicine, Medical 

Laboratory Sciences, Department of Pathology (2010-2012). Since 2007, she has been the 

medical laboratory director of the Southern Nevada Adult Mental Health Services (SNAMHS) 

Rawson-Neal Psychiatric Hospital in Las Vegas, Nevada, and in 2012 was appointed to the 

Board of Directors, American Board of Toxicology (ABT) where she is chair of the 
2 

Globalization Committee and serves on several other ABT committees. Dr. Keil served as a 

review panel member for the EPA Science Advisory Board Trichloroethylene Health 

Assessment review in 2010. She served as the secretary/treasurer for the Society of Toxicology’s 

(SOT) Women in Toxicology special interest group and on several SOT immunotoxicology 

specialty sections. The focal point of her research is the immunotoxicological effects of a variety 

of environmental and occupational chemicals, including trichloroethylene, perfluorinated 

compounds, jet-fuel and DEET. Dr. Keil has published nine book chapters and more than 30 

peer- reviewed articles, as well as some 70 proceedings/abstracts and presentations. 

Dr. Kathleen M. Gilbert is Professor with the Department of Microbiology and Immunology at 

the University of Arkansas for Medical Sciences (UAMS). She received her B.S. degree in 

Biology from Occidental College in Los Angeles, California, and her Ph.D. degree in 

Immunology from Tulane University, New Orleans, Louisiana. At the Sloan-Kettering Institute, 

New York, New York, Dr. Gilbert was a postdoctoral research associate (1980 -1982) and a 

research associate (1982-1985), followed by an appointment as a Visiting Worker at the National 

Institute for Medical Research, London, United Kingdom (1985-1987) and positions with the 

Department of Immunology, The Scripps Research Institute, La Jolla, California, as senior 

research associate (1987-1991) and assistant member (assistant professor) (1991-1994) before 

joining UAMS in 1994. She holds secondary appointments at the UAMS Department of 

Pediatrics (2002) and Department of Pharmacology and Toxicology (2010). Among other 

projects, Dr. Gilbert’s laboratory is studying how different environmental toxicants including 

trichloroethylene (TCE) found in the water supply promote autoimmune disease. This study uses 

MRL+/+ mice and examines the various immune system changes and tissue pathology that occur 

when these mice are exposed to environmental concentrations of TCE alone or in the presence of 

other toxicants. Mechanistic studies concerning how these chemicals promote T cell activation 

via epigenetic modifications also are under way. This involves examining how the developing 

immune system in children is especially susceptible to toxicant exposure that may lead to laterlife disease. Dr. Gilbert has published 56 peer-reviewed journal articles, 10 book chapters, in 

addition to 50 abstracts/posters and platform presentations, and more than 25 invited 

presentations. Dr. Gilbert was a Postdoctoral Fellow with the U.S. Public Health Service (1980-

1983) and for 25+ years has received extramural research funding from EPA, National Science 

Foundation, National Arthritis Foundation, Arthritis Foundation, Arkansas Chapter American 

Cancer Society, the National Institute of Environmental Health Sciences and other funding 

organizations. She currently is editing a book on the human health effects of TCE. 

 

Dr. Timur S. Durrani is a Clinical Instructor of Medicine at the University of California, San 

Francisco (UCSF), where he holds dual appointments in the Department of Medicine, Division 

of Clinical Pharmacology and Experimental Therapeutics and Department of Family Medicine. 

Dr. Durrani earned his Medical Degree from the University of Arizona, where he also earned his 

M.P.H degree. He holds dual board certifications in Family Medicine and Preventive Medicine, 

and is a recent graduate of the UCSF Occupational and Environmental Medicine Residency and 

the UCSF Medical Toxicology Fellowship. His academic responsibilities include teaching 

medical and pharmacy students as well as graduate medical trainees, including Emergency 

Medicine and Occupational and Environmental Medicine residents and Medical Toxicology 

Fellows. He provides clinical care for acutely poisoned patients at the San Francisco General 

Hospital, where he is a consultant for the Medical Toxicology Service, as well as outpatient 
3 

Medical Toxicology consultations through the UCSF Occupational and Environmental Medicine 

Faculty Practice. He serves as Medical Toxicology consultant for the Agency for Toxic 

Substances and Disease Registry, Region 9 and the EPA, Region 9. Dr. Durrani has publications 

in basic science and public health disciplines, and has presented abstracts in neurotoxicology. 

Dr. James Robert Cerhan is Professor of Epidemiology at the Mayo Clinic College of 

Medicine in Rochester, Minnesota, where he chairs the Department of Health Sciences Research 

and is a consultant to the Division of Epidemiology. He also is an adjunct professor at the 

Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City. 

Dr. Cerhan received his B.A. in Anthropology from The University of Iowa and his Ph.D. in 

Epidemiology from The University of Iowa, Graduate College, followed by a Postdoctoral 

Fellowship in Cancer Epidemiology with the University of Minnesota, School of Public Health 

and an M.D. from The University of Iowa, College of Medicine. His areas of expertise are cancer 

etiology, prevention, and control for non-Hodgkin lymphoma, chronic lymphocytic leukemia, 

prostate, and breast cancer, as well as molecular and genetic epidemiology. He has served on 

several external advisory boards, including the Minnesota Department of Public Health, Cancer 

Surveillance System Advisory Group (2008-Present), the University of Southern California 

Program Project Grant: Iatrogenic Causes of Cancer (2003-2008), and the Genentech, South San 

Francisco, California, National LymphoCare Study (2004-Present). In addition, he has been an 

invited participant in numerous meetings, including the National Institute for Environmental 

Health Sciences Environmental Epidemiology in the Twenty-First Century Workshop (1999), 

the National Cancer Institute Consortium on Familial CLL (2000), the International Agency for 

Cancer Research NATO Advanced Research Workshop: Second Meeting Regarding the 

InterLymph Collaborative Project—Perspectives of Epidemiologic Research on Non-Hodgkin’s 

Lymphomas (2002), and the RAND Corporation Anaplastic Large Cell Lymphoma (ALCL) & 

Breast Implants Expert Panel Meeting (2010). He has made more than 100 presentations at 

national and international meetings and published more than 300 articles, including a paper on 

occupational exposure to trichloroethylene and non-Hodgkin lymphoma. He has been a reviewer 

for many scientific journals, including Lancet, New England Journal of Medicine, JAMA, and the 

American Journal of Epidemiology and has served on several editorial boards, including current 

positions on the International Journal of Molecular Epidemiology & Genetics and Cancer 

Research. 

Dr. Ronald L. Melnick is a private consultant, Ron Melnick Consulting, LLC. He received his 

B.S. degree in Food Science from Rutgers University, New Brunswick, New Jersey, and his 

M.S. and Ph.D. degrees in Food Science/Biochemistry from the University of Massachusetts, 

Amherst. He was a postdoctoral research fellow in the Department of Physiology-Anatomy at the 

University of California in Berkeley and then an assistant professor of Life Sciences at the 

Polytechnic Institute of New York. Dr. Melnick served as a toxicologist for 28+ years at the 

National Institute of Environmental Health Sciences’ (NIEHS) National Toxicology Program 

(NTP) for the toxicology/carcinogenesis studies on 1,3-butadiene, water disinfection byproducts, 

chloroprene and other chemicals as well as the NIEHS Division of Biometry and Risk 

Assessment and NIEHS Environmental Carcinogenesis Program. He was the manager of the 

NIEHS Experimental Toxicology Unit, Carcinogenesis and Toxicology Evaluation Branch, and 

group leader of the NIEHS Toxicokinetics and Biochemical Modeling Group, Laboratory of 

Computational Biology and Risk Analysis, Environmental Toxicology Program. He spent 1 year 
4 

as an agency representative to the White House Office of Science and Technology Policy to 

work on interagency assessments of health risks of environmental agents and on risk assessment 

research needs in the federal government. He served on more than 40 advisory boards. He also 

was a member of EPA’s Science Advisory Board to review the document “Trichloroethylene 

Health Risk Assessment: Synthesis and Characterization” (2002); a working group member 

(chair of the section on cancer studies in experimental animals) of the International Agency for 

Research on Cancer for the preparation of volume 106 of the IARC Monograph on the 

Evaluation of Carcinogenic Risks to Humans: Trichloroethylene and other chlorinated agents 

(2012); a reviewer of the National Research Council’s (NRC) report, “Review of EPA’s Draft 

IRIS Assessment on Tetrachloroethylene,” written by the NRC’s Board on Environmental 

Studies and Toxicology; and a member of the Integrated Risk Information System (IRIS) 

external peer review panel of EPA’s “Toxicological Review of Trichloroacetic Acid.” He has 

been a reviewer for Environmental Health Perspectives—on whose editorial board he served 

(1991-1997), Cancer Research, Carcinogenesis, Critical Reviews in Toxicology, Fundamental 

and Applied Toxicology/Toxicological Sciences, Journal of the National Cancer Institute and 

other journals. Dr. Melnick has published 15 book chapters, 18 technical reports, 127 journal 

articles, delivered 43 invited lectures, and is the recipient of the American Public Health 

Association’s 2007 David P. Rall Award for science-based advocacy in public health. 

Dr. Kenneth M. Portier is Managing Director of the Statistics & Evaluation Center at the 

American Cancer Society (ACS) Corporate Center in Atlanta, Georgia, Affiliate Professor of 

Biostatistics in the School of Public Health, Emory University, and Courtesy Professor in the 

Center for Environmental and Human Toxicology at the University of Florida. Dr. Portier has a 

B.S. degree in mathematics (1973) from Nicholls State University in Thibodaux, Louisiana, as 

well as an M.S. degree in Statistics (1975) and a Ph.D. degree in Biostatistics (1979) from the 

University of North Carolina, Chapel Hill. With ACS since early 2006, Dr. Portier provides 

general statistical support on design and analysis of cross-sectional and longitudinal sample 

surveys and evaluations of ACS support programs. Prior to ACS, he spent 27 years as a 

statistical consultant to researchers in agriculture, natural resources and the environment and as a 

teacher of applied statistics at the University of Florida. Dr. Portier has co-authored more than 

170 publications in many of the premier journals in agriculture, natural resources and 

environmental sciences. He served on EPA’s Federal Insecticide, Fungicide, and Rodenticide 

Act (FIFRA) Science Advisory Panel (FIFRA-SAP) from 2004 to 2012, the U.S. National 

Toxicology Program (NTP) Board of Scientific Counselors (2007-2009) and a number of other 

EPA, NTP, National Institutes of Health (NIH), and World Health Organization/Food and 

Agriculture Organization expert panels, most recently the NIH Breast Cancer and Environmental 

Research Coordinating Committee. His present research focus is on multivariate text mining 

techniques applied to the analysis of online cancer forum posts. 

Dr. Calvin Willhite is a Contract Toxicologist with Risk Sciences International and McLaughlin 

Centre for Population Health Risk Assessment (Ottawa, Ontario, Canada). He received his B.S. 

degree in Zoology and his M.S. degree in Toxicology from Utah State University, where he also 

held positions as adjunct assistant and adjunct associate professor of Toxicology. He received his 

Ph.D. degree in Pharmacology from Dartmouth Medical School. He also was a Postdoctoral 

Fellow at the University of Arizona, College of Medicine, Department of Pharmacology, 

conducting research on inhalation toxicology and developmental toxicology. From 1985 to 2011, 
5 

he was the staff toxicologist for the State of California, involved in hazardous waste site human 

health risk assessments, developing and publishing chemical-specific human health risk 

assessments, and serving as reproduction and developmental toxicity research contract manager. 

Dr. Willhite has published more than 100 articles in basic and applied toxicology research 

funded by the National Institutes of Health (NIH), U.S. Department of Agriculture, March of 

Dimes, the International Life Sciences Institute, National Science Foundation, the International 

Agency for Research on Cancer, the State of California and Hoffmann-La Roche. The 

constituents of his research range from chemicals in occupational, submarine and ambient air; 

drugs in dermatology; endocrine-active drugs and environmental chemicals; inorganic elements 

and dietary supplements to regulated hazardous waste sites. He managed $2.2 million for the 

State of California human health risk assessments for drinking water contaminants in support of 

Maximum Contaminant Level promulgation. He has been a member of several EPA advisory 

committees, including the National Advisory Committee for Acute Exposure Guideline Levels 

(2006-2009); the Trichloroethylene Issues Group, U.S. Air Force and EPA (1993); the Integrated 

Risk Information System (IRIS) Hexachlorobutadiene Peer Review Panel and the Peer Review 

Study Section, “Reducing Uncertainty in Risk Assessment and Improving Risk Reduction 

Approaches” (1995). In addition, he has served on advisory committees for the National 

Academy of Sciences (NAS), including the NAS Committee on Toxicology (2001-2004), 

National Institute of Environmental Health Sciences (NIEHS)/National Toxicology Program 

Scientific Advisory Committee on Alternative Toxicological Methods (2003-2006), and NIH. 

Dr. Jeffrey Driver is a Principal at risksciences.net, LLC, a consulting firm that conducts risk 

analyses for consumer products, occupational, public, and environmental scenarios involving 

chemical, biological or physical agents. He obtained his B.S. degree in Biology and Chemistry 

(1983) from Bridgewater College, Virginia, and his M.P.H. (1986) and Dr.P.H. degrees (1988) in 

Biohazard Science (Parasitology and Laboratory Practice, and Environmental Sciences and 

Engineering Programs) from the University of North Carolina at Chapel Hill, School of Public 

Health. Dr. Driver is a Diplomat of the American Board of Toxicology and is a licensed Medical 

Technologist (American Society of Clinical Pathologists) and Clinical Laboratory Scientist 

(National Certification Agency). He is an adjunct faculty member at George Mason University, 

and has been an Adjunct Associate Professor of Medicine in the Division of Occupational and 

Environmental Medicine, Department of Medicine, George Washington University Medical 

Center. He has served as a counselor for the International Society of Regulatory Pharmacology 

and Toxicology. Dr. Driver was a visiting scientist in EPA’s Genetic Toxicology Division, 

Genetic Bioassay Branch (Research Triangle Park, NC), a research scientist at the National 

Institutes of Health, Division of Safety, and a research scientist at the National Cancer Institute, 

Frederick Cancer Research Facility, Environmental Control and Research Program. Dr. Driver 

also was an adjunct associate professor of medicine (Guest Lecturer) at the School of Public 

Health & Health Services, George Washington University Medical Center (1993-1997 and 1997-

2004) and adjunct associate professor of Biology, Environmental Sciences and Public Policy at 

George Mason University, Fairfax, Virginia (1989-1994). Prior to co-founding risksciences.net, 

LLC and infoscientific.com, Inc., he was assistant director of the Toxicology Division at 

Technology Sciences Group, Inc., a subsidiary of McKenna Long & Aldridge. 
6 

Dr. P. Barry Ryan is Professor of Exposure Science and Environmental Chemistry in the 

Department of Environmental Health, Rollins School of Public Health, Emory University, 

Georgia, where he is jointly appointed in the Department of Chemistry. Prior to joining the 

faculty at Emory in 1995, he was on the faculty at Harvard School of Public Health. He received 

a B.S. degree in Chemistry from the University of Massachusetts, an M.S. in Physical Chemistry 

from the University of Chicago, and a Ph.D. degree in Computational Chemistry from Wesleyan 

University, Connecticut. He has been active in the exposure assessment field for more than 25 

years and has published in excess of 110 peer-reviewed manuscripts and book chapters and made 

more than 200 presentations of his work to the scientific community. His work has included both 

cross-sectional and longitudinal studies of community-based exposure for multiple pollutants in 

multiple media. Dr. Ryan is a principal investigator on a study assessing exposure to pesticides 

experienced by individuals in a community in Northern Thailand. In addition, he is co-principal 

investigator and co-investigator on three separate Formative Research projects associated with 

the National Children’s Study, including a large-scale longitudinal study of exposure biomarkers 

in pregnant African-American women. Finally, he is a principal investigator of a study of the 

impact of a commuter airport on noise and air pollution in the surrounding community. He 

recently concluded work as principal investigator of a retrospective study of exposure to 

perfluorooctanoic acid in a large area surrounding a manufacturing facility using this compound. 

Dr. Ryan served a 6-year term as a member of the Board of Scientific Counselors for EPA’s 

Office of Research and Development and a member of EPA’s Science Advisory Board 

Subcommittee on Exposure and Human Health. Dr. Ryan also completed a 4-year term on the 

Federal Advisory Committee for the National Children’s Study being undertaken by the National 

Institutes of Health. He has served on numerous advisory panels for EPA, most recently as a 

member of EPA’s Federal Insecticide, Fungicide, Rodenticide Act Science Advisory Panel on 

Chlorpyrifos Health Effects. Dr. Ryan also has served on several National Academy of Science 

panels. 

Dr. Penelope A. Fenner-Crisp (proposed chair) works as a private consultant after retiring as 

the executive director of the ILSI Risk Science Institute (RSI) in 2004. She received her B.S. 

degree in Zoology from the University of Wisconsin-Milwaukee and her M.A. and Ph.D. degrees 

in Pharmacology from the University of Texas Medical Branch in Galveston, where her research 

interests were in neuro- and cardiovascular pharmacology. She completed a Postdoctoral 

Fellowship in Pharmacology-Morphology from the Pharma Foundation in the Anatomy 

Department of the Georgetown University Schools of Medicine and Dentistry, with an emphasis 

on reproductive endocrinology (1971-1973). Before joining EPA in 1978, she was an adjunct 

instructor in the Anatomy Department and a research associate in the Pharmacology Department 

at Georgetown University, Washington, D.C. During her more than 22 years at EPA, Dr. FennerCrisp served as senior science advisor to the director and the deputy director of the Office of 

Pesticide Programs and the director of its Health Effects Division. She was a special assistant to 

the assistant administrator for Prevention, Pesticides and Toxic Substances and also served as 

director of the Health and Environmental Review Division of the Office of Pollution Prevention 

and Toxics (OPPT). Before that, she was a senior toxicologist in the Health Effects Branch of the 

Office of Drinking Water. Her responsibilities at EPA included both the hands-on practice, and 

management oversight, of developing all components of both human health and ecological risk 

assessments related to drinking water contaminants, industrial chemicals and pesticides. She was 

a charter member of the Risk Assessment Forum (RAF), a group of Agency senior scientists who 
7 

are expert in all areas of human, ecological and exposure assessment, and served as the RAF 

chair from 1998 until her retirement from EPA in 2000. While at EPA, Dr. Fenner-Crisp oversaw 

the development of the non-regulatory Health Advisory for TCE, as well as for other related 

chlorinated volatile organics; oversaw periodic human health risk assessment activities related to 

TCE, tetrachloroethylene (PCE) and other related chlorinated organic solvents; served on an 

expert peer review panel charged with reviewing the draft IRIS document on Trichloroacetic 

acid, a known and significant TCE metabolite. She has co-authored several articles and given 

several presentations that describe the current state-of-the-science of the hypothesized mode of 

action underlying rodent tumors observed following long-term exposure to peroxisome 

proliferator activating alpha receptor (PPARα) agonists. TCE is a PPARα agonist that fits this 

profile. 

Dr. Michael Jayjock is a Senior Analyst with The LifeLine Group, a nonprofit organization 

dedicated to the development of scientific tools for human exposure and risk assessment. He has 

been with LifeLine for 7 years. He also is a Sole Proprietor of Jayjock Associates, LLC, a forprofit consultancy. Previous to this, he was a senior research and environmental health and safety 

fellow and manager for risk assessment at the Rohm and Haas Company, and had been working 

with that company for 35 years. In his current position, he is responsible for the determination of 

human health risk from and development of tools for the evaluation of human exposure and risk 

to chemicals. Dr. Jayjock received both his Ph.D. degree in Environmental Engineering and his 

M.S. degree in Environmental Science and Occupational Health from Drexel University, 

Pennsylvania. He is a Fellow of the American Industrial Hygiene Association and is certified in 

the Comprehensive Practice of Industrial Hygiene by the American Board of Industrial Hygiene. 

His professional activities include such areas as exposure modeling research, human 

exposure/risk assessment to environmental pollutants and uncertainty analysis. He has published 

extensively in peer-reviewed publications and served from 1998 to 2003 as an Editorial Board 

Member for the American Industrial Hygiene Journal. He has made numerous technical 

presentations, including at the American Industrial Hygiene Conferences and International 

Society of Exposure Assessment Conferences. His service on advisory committees includes: 

EPA’s Board of Scientific Counselors Peer Review Panel for the Office of Research and 

Development, Executive Committee, Human Health Research Strategy Panel; EPA Office of 

Pollution Prevention & Toxics - Voluntary Children’s Chemical Evaluation Program (VCCEP), 

Peer Consultation Panel on Flame Retardants (2003) and Methyl Ethyl Ketone (2004); EPA’s 

Science Advisory Board (SAB), Executive Committee, Human Health Research Strategy Panel 

(November 2002); EPA’s SAB, consultant - Integrated Human Exposure Committee (2001-

2003); EPA SAB member - Integrated Human Exposure Committee (1998-2001); and National 

Research Council - National Academy of Sciences, as a Member of the Committee to Review 

Risk Management in the Department of Energy’s Environmental Remediation Program, the 

Committee on Advances in Assessing Human Exposure to Airborne Pollutants, and the 

Committee on Toxicology - Subcommittee on Risk Assessment of Flame-Retardant Chemicals. 

Dr. David A. Morgott is a board certified toxicologist and industrial hygienist who has been the 

Owner and Principal Scientist at Pennsport Consulting, LLC, since 2006. Prior to that time, he 

was a staff scientist at Eastman Kodak Company’s Health, Safety, and Environment laboratory 

for more than 20 years. During his tenure at Kodak, he held positions within the Worldwide 

Toxicology Group, the Scientific and Regulatory Analysis Group, the Industrial Hygiene 
8 

Section, and the Biochemical Toxicology Section (1986 -2007). He earned a B.S. degree in 

Medical Technology from the State University of New York at Buffalo, and an M.P.H. degree in 

Industrial Hygiene and Ph.D. degree in Toxicology from the University of Michigan. He served 

a 2-year postdoctoral appointment at Dow Chemical Company’s Health Safety and Environment 

laboratory, where his specialties were the metabolism and pharmacokinetics of vapor phase 

chemicals (1984-1986). Dr. Morgott has served on numerous technical committees, including 

the American Industrial Hygiene Association’s Biological Monitoring Committee, the Society of 

Toxicology Occupational Health Specialty Section, and the Chemical Specialties Manufacturers 

Association’s VOC Reactivity Task Group. He has been a contributing author on many chemical 

reviews, white papers and risk assessments; and has published repeatedly on the metabolism and 

pharmacokinetics of volatile solvents. Dr. Morgott has written four book chapters for Patty’s 

Industrial Hygiene and Toxicology, served as a peer reviewer for many toxicology-related 

journals, and regularly presented and organized panel sessions at recognized national meetings. 

His present interests range from exposure and risk modeling to the health effects of primary air 

pollutants. 

Dr. Montserrat Fuentes is Head and Full Professor of Statistics at North Carolina State 

University (NCSU). Dr. Fuentes received her B.S. degree in Mathematics and Music (piano) 

from the University of Valladolid, Spain, and her Ph.D. degree in Statistics from the University 

of Chicago (1999). Dr. Fuentes has authored more than 70 scientific publications and served as a 

principal investigator (or co-PI) on more than 20 research grants, with total funding of more than 

$20 million. She is the principal investigator and director of the Research Network for Statistical 

Methods for Atmospheric and Oceanic Sciences (STATMOS), a $5 million initiative funded by 

the National Science Foundation. Dr. Fuentes was named an American Statistical Association 

fellow (2008) for outstanding contributions to research in spatial statistics, for excellence in the 

development and application of statistical methodology in atmospheric sciences, air pollution 

and oceanography; and for service to the profession. She is the editor of the Journal of 

Agricultural, Biological, and Environmental Statistics (JABES), of the International Biometrics 

Society. Dr. Fuentes is a member-elect of the International Statistical Institute, and has been a 

member of the Regional Advisory Board for the Eastern North American Region of the 

International Biometric Society. Dr. Fuentes is a member of EPA’s Science Advisory Board 

(SAB) Integrated Human Exposure Committee, and the U.S. representative on the Board of 

Directors of the International Environmetrics Society. She was a member of the Biostatistical 

Methods and Research Design (BMRD) study section of the National Institutes for Health, and 

she is currently a member of the scientific review committee of Health Canada. She also has 

worked for the U.S. Department of Justice as an expert witness and was a member of a 

committee of the National Research Council of the National Academies working on the impact 

of ozone on mortality. She is a senior leader of the ADVANCE-NSF Developing Diverse 

Departments program at NCSU. Dr. Fuentes was recently awarded the NCSU 2013 Equity of 

Women award for major contributions to the equity and well-being of women at NC State 

University.